Skip to main content

Knee Reconstruction Equipment Market | Size, Share, Growth Analysis

Major players profiled in the global knee reconstruction equipment market report include Zimmer, Inc. (U.S.), Stryker (U.S.), DePuy Synthes (U.S.), Smith & Nephew plc (U.K.), Arthrex, Inc. (U.S.), Exactech, Inc. (U.S.), Corin (U.K.), DJO Global (U.S.), Japan Medical Dynamic Marketing, Inc. (Japan), Tornier, Inc. (Netherlands), and United Orthopedic Corporation (Taiwan), among others.
Key stakeholders of knee reconstruction equipment market include orthopedic implant manufacturing companies, distributors of medical devices, healthcare institutions (hospitals, medical schools, and governing bodies), health insurance players, research and consulting firms, and regulatory authorities such as Food and Drug Administration (FDA).
Technological advancements in the global knee reconstruction equipment market, such as newly developed prostheses with improved strength and reliability of joints, are reducing the need and cost of revision surgeries. Additionally, the rising healthcare expenditure is a positive sign for the growth of this market during the forecast period, 2015 to 2020.
The global knee reconstruction equipment market was led by the Americas in 2014. It was followed by market in the European and Asia-Pacific regions. China, Japan, India, the Republic of Korea, Australia, Singapore, New Zealand, Thailand, Malaysia, Indonesia, Taiwan, and Vietnam are the countries of the Asia-Pacific market covered in this report. The Asia-Pacific knee reconstruction devices market is expected to grow at a CAGR of 6.1% from 2015 to 2020. Some of the Asian countries, such as India, Thailand, and Malaysia, among others are becoming well-known destinations for medical tourism as they offer low-cost knee reconstruction procedures and high quality health care.

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...